Oradexon (Dexamethasone Sodium Phosphate)

Dexamethasone sodium phosphate, the active ingredient in Oradexon, is a corticosteroid presented as a sterile injectable solution for intravenous use. It is employed to reduce inflammation and modulate immune responses in a variety of acute and chronic medical conditions. GNH USA supplies Oradexon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Oradexon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Oradexon, a corticosteroid, is used in clinical situations that require rapid anti‑inflammatory and immunosuppressive effects.

- Severe allergic reactions: helps manage symptoms such as airway swelling and hypotension. - Cerebral edema: reduces intracranial pressure associated with brain tumors or trauma. - Post‑operative inflammation: limits swelling and pain after major surgery. - Acute asthma exacerbations: improves airflow by decreasing airway inflammation. - Certain autoimmune disorders: controls disease activity in conditions like systemic lupus erythematosus. - Chemotherapy‑related nausea and vomiting: enhances anti‑emetic regimens.

Adverse reactions to dexamethasone sodium phosphate vary with dose and duration of therapy.

Common Side Effects: - Hyper‑hyper‑hyper    -   -  -  -  - 

Serious or Rare Side Effects: -  - 

Oradexon requires careful monitoring because of its potent systemic effects.

- Assessment  :   -  -  -  -  - Store  :  ullet   ewline   ewline    ewline  ullet